| Autor: |
Hajijafari, Mohammad, Banafshe, Hamid Reza, Asgarian, Fatemeh Sadat, Ahsaniaran, Amir Hossein, Matini, Amir Hassan, Momen-Heravi, Mansooreh |
| Předmět: |
|
| Zdroj: |
International Archives of Health Sciences; Jul2023, Vol. 10 Issue 2, p31-39, 9p |
| Abstrakt: |
Objectives: We will try to present cases of coinfection with COVID-19 and mucormycosis in Kashan to increase the awareness of health-care providers and reduce the number of forgotten and neglected cases. Methods: This is a descriptive cross-sectional study that patients infected with COVID-19 become vulnerable to a variety of opportunistic diseases. There are several studies of COVID-19 and mucormycosis, but an effort has been made to provide a collection of cases in Kashan (the center of Iran) to reduce morbidity and mortality by increasing the awareness of health-care providers. Results: A total of 31 patients with mucormycosis following COVID-19 including 18 males and 13 females were included in the study. All reverse transcriptase-polymerase chain reaction patients were positive for severe acute respiratory syndrome-coronavirus-2. Twenty had a history of diabetes, eight had a history of hypertension, and three had no record of any underlying disease. The maxillary sinuses were the most common site of involvement. The maximum length of hospital stay was 52 dayss. Conclusion: Patients with COVID-19 vulnerable to comorbidities, any facial involvement, or severe glucocorticoid and antibiotic treatment should be closely examined and monitored at the first encounter and during hospitalization for any signs of mucormycosis and start standard care and antifungal treatment as soon as possible. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
